5-HT(1A) receptor agonist properties of the antipsychotic, nemonapride: Comparison with bromerguride and clozapine

European Journal of Pharmacology

Volumn 334, Issue 2-3, 1997, Pages 141-147

  Assié, Marie Bernadette ^a   Cosi, Cristina ^a   Koek, Wouter ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

5 HT (5 hydroxytryptamine serotonin); 5 HT(1A) receptor; Antipsychotic; CAMP accumulation; Extracellular concentration; HA7 cells; Microdialysis

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; BROMERGURIDE; CLOZAPINE; CYCLIC AMP; DOPAMINE RECEPTOR BLOCKING AGENT; EMONAPRIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RACLOPRIDE; SEROTONIN; SEROTONIN 1A AGONIST; BENZAMIDE DERIVATIVE; DOPAMINE 2 RECEPTOR; DRUG DERIVATIVE; LISURIDE; NEUROLEPTIC AGENT; SEROTONIN 1 RECEPTOR; SEROTONIN AGONIST; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HELA CELL; HIPPOCAMPUS; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; BENZAMIDES; CLOZAPINE; CYCLIC AMP; DOPAMINE ANTAGONISTS; HELA CELLS; HIPPOCAMPUS; HUMANS; LISURIDE; MALE; MICRODIALYSIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN; SEROTONIN AGONISTS;

EID: 0030609085     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01207-7     Document Type: Article

References (40)

1. 1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties. Eur. J. Pharmacol. 304, 15-21.
2. 1B receptors. Neuropharmacology 35, 213-222.
3. 3H]YM-09151-2 binding in the rat brain by thioridazine, risperidone and clozapine, but not by other antipsychotics. Eur. J. Pharmacol. 237, 183-189.
4. 1A receptors are not involved in clozapine's lack of cataleptogenic potential. Neuropharmacology 35, 1645-1646.
5. 1A receptors. J. Neurochem. 66, 2546-2555.
6. 1A receptor. J. Biol. Chem. 264, 14848-14852.
7. Ferré, S., Artigas, F., 1995. Clozapine decreases serotonin extracellular levels in the nucleus accumbens by a dopamine receptor-independent mechanism. Neurosci. Lett. 187, 61-64.
8. Fink, H., Morgenstern, R., Ott, T., 1991. 2-Bromolisuride, an ergot derivative, with dopamine antagonistic and serotonin agonistic properties. Pharmacol. Biochem. Behav. 38, 321-325.
9. 1A receptor antagonist. Behav. Brain Res. 73, 337-353.
10. Fuller, R.W., 1994. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci. 55, 163-167.
11. 1A receptor antagonist WAY-100635 on hippocampal 5-HT release in vivo, Br. J. Pharmacol. 112, suppl., 299P.
12. 1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol. J. Pharmacol. Exp. Ther. 265, 707-712.
13. 1-adrenoceptors in the inhibition of 5-HT release - I. BMY7378 and prazosin. Neuropharmacology 34, 615-620.
14. Kapur, S., Remington, G., 1996. Serotonin-dopamine interaction and its relevance to schizophrenia. Am. J. Psychiatry 153, 466-476.
15. 2 receptor antagonists to inhibit methylphenidate-induced behaviors in rats. Eur. J. Pharmacol. 313, 25-34.
16. 1A autoreceptors of the dorsal and median raphe nuclei. J. Pharmacol. Exp. Ther. 269, 1268-1279.
17. Kulkarni, S.K., Verma, A., 1993. Neuropharmacology of clozapine, an atypical antipsychotic. Drugs Today 29, 469-475.
18. 1A receptors. Eur. J. Pharmacol. 260, 79-83.
19. Liau, L.M., Sleight, A.J., Pitha, J., Peroutka, S.J., 1991. Characterization of a novel and potent 5-hydroxytryptamine 1A receptor antagonist. Pharmacol. Biochem. Behav. 38, 555-559.
20. Löschmann, P.-A., Horowski, R., Wachtel, H., 1992. Bromerguride - an ergoline derivative with atypical neuroleptic properties. Clin. Neuropharmacol. 15 (suppl. 1), 263A-264A.
21. 1A receptors in human brain tissue. Eur. J. Pharmacol. 221, 397-398.
22. 76Br]Bromolisuride: a new tool for quantitative in vivo imaging of D-2 dopamine receptors. Eur. J. Pharmacol. 127, 239-247.
23. i values. J. Pharmacol. Exp. Ther. 251, 238-246.
24. 1A receptors. Neuropharmacology 35, 119-121.
25. 1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells. Biochem. Pharmacol. 45, 375-383.
26. Paxinos, G., Watson, C., 1986, The rat brain in stereotaxic coordinates, Academic Press, New York.
27. Prinssen, E.P.M., Kleven, M.S., Koek, W., 1996. Effects of dopamine antagonists in a two way active avoidance procedure in rats: Interactions with 8-OH-DPAT, ritanserin, and prazosin. Psychopharmacology 128, 191-197.
28. 1-adrenoceptor antagonists differentially control serotonin release in the hippocampus and striatum: A microdialysis study. Eur. J. Pharmacol. 261, 59-64.
29. Satoh, K., Someya, T., Shibasaki, M., 1997. Nemonapride for the treatment of schizophrenia. Am. J. Psychiatry 154, 297.
30. 4 receptors. Neuropsychopharmacology 16, 93-110.
31. 1A autoreceptor function. Advances in the Biosciences 85, 297-323.
32. Sharp, T., Bramwell, S.R., Hjorth, S., Grahame Smith, D.G., 1989. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. Br. J. Pharmacol. 98, 989-997.
33. 3) as a target for neuroleptics. Nature 347, 146-151.
34. Tanaka, M., 1992. Nemonapride, Drugs of Today 28, 25-28.
35. 3H]raclopride for dopamine D-2 receptor binding to rat striatum. Eur. J. Pharmacol. 173, 177-182.
36. Usuda, S., Nishikori, K., Noshiro, O., Maeno, H., 1981. Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3yl)-5-chloro-2-methoxy-4-met hylaminobenzamide (YM-09151-2) with selective antidopaminergic activity. Psychopharmacology 73, 103-109.
37. Wachtel, H., Sauer, G., 1988. Bromerguride. Drugs Future 13, 403-405.
38. Wachtel, H., Kehr, W., Sauer, G., 1983. Central antidopaminergic properties of 2-bromolisuride, an analogue of the ergot dopamine agonist lisuride. Life Sci. 33, 2583-2597.
39. Wadenberg, M.L., 1996. Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat. Neurosci. Biobehav. Rev. 20, 325-339.
40. Wadenberg, M.L., Ahlenius, S., 1991. Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy. J. Neural Transm. 83, 43-53.